International Edition
Latest News
Health

Pharmacists Stress Context of Glucose Data to Avoid Unwarranted Drug Changes

Daily blood glucose readings can trigger unnecessary medication changes unless providers examine the context behind the numbers. Continuous glucose monitoring makes tracking easier, but optimal use requires proper review and interpretation of data, according to the American Diabetes…

Pharmacists Stress Context of Glucose Data to Avoid Unwarranted Drug Changes

Daily blood glucose readings can trigger unnecessary medication changes unless providers examine the context behind the numbers.

Continuous glucose monitoring makes tracking easier, but optimal use requires proper review and interpretation of data, according to the American Diabetes Association.

“has particularly impacted how pharmacists can support people with diabetes on a daily basis through using data to educate people about how their medications, how their physical activity and lifestyle, and other factors impact their blood glucose,”

Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, senior vice president of medical affairs at the American Diabetes Association, said in an interview with Pharmacy Times.

When patients demonstrate their testing technique at the pharmacy, simple procedural fixes often resolve poor numbers that initially appear to be a lack of adherence, according to Christina Hudspeth, PharmD.

“She was actually taking the lancet itself and essentially jabbing it directly into her finger,”

Hudspeth told Pharmacy Times regarding a patient who was skipping her lancing device entirely because testing felt painful and frustrating.

“Sometimes we assume a patient is just not adherent,” Christina Hudspeth, PharmD, said.

Device failures and external factors can similarly distort meter results. The American Diabetes Association lists expired or improperly stored test strips, abnormal hematocrit, and low oxygen tension from high altitudes among factors affecting meters. Continuous glucose monitor users should rely on a traditional meter while a sensor warms up, and medications such as acetaminophen and vitamin C can falsely raise sensor values depending on the specific sensor used.

Context protects patients from unwarranted medication adjustments when logs reach a prescriber. A clinician might otherwise be led to inappropriately step up drug treatment if they see an isolated 200 mg/dL value alongside steady 100 mg/dL measurements, as noted by Nicole Paolini Albanese, PharmD, CDCES, BCACP, a clinical associate professor at the University at Buffalo School of Pharmacy and Pharmaceutical Sciences.

“This was an outlier because I was out the night before and I had a bottle of wine,”

Albanese told Pharmacy Times, citing how an explanation from a patient provides a much more accurate picture for the care team.

Nicole Paolini Albanese, PharmD, CDCES, BCACP, serves as a clinical associate professor at the University at Buffalo School of Pharmacy and Pharmaceutical Sciences, where she teaches within the Department of Pharmacy Practice.

Her quoted expertise in the article — illustrating how patient context prevents inappropriate medication escalation from isolated glucose readings — reflects the school’s role in advancing clinical pharmacy education and research on diabetes management through faculty who directly shape guideline-directed care and collaborative practice models.

Collaborative practice agreements allow pharmacists in some practices to assume increased responsibility by initiating, modifying, or discontinuing drug therapy. Pharmacists are ideally situated to step in and close deficiencies concerning patient education, care coordination, the availability of treatments and devices, and the refinement of guideline-directed care, Neumiller noted.

About the author: Health Desk

Health Desk at Archynewsy.